Anavex Life Sciences Corp.
AVXL
$9.53
-$0.02-0.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 71.69% | -16.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.42% | -5.79% | |||
| Operating Income | -15.42% | 5.79% | |||
| Income Before Tax | -18.28% | 7.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.28% | 7.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.28% | 7.56% | |||
| EBIT | -15.42% | 5.79% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -17.86% | 7.84% | |||
| Normalized Basic EPS | -17.74% | 7.84% | |||
| EPS Diluted | -17.86% | 7.84% | |||
| Normalized Diluted EPS | -17.74% | 7.84% | |||
| Average Basic Shares Outstanding | 0.36% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||